AbbVie ABBV
NYSE ABBV
$276.48 +4.06 (+1.49%)
At close: Oct 9, 2026 · 4:00 PM EDT

AbbVie (ABBV) Depreciation & Amortization (CF) (2012 - 2026)

Updated

AbbVie's Depreciation & Amortization (CF) was $194 million in Q2 2026, up 4.3% from $186 million a year earlier and up 3.2% from the prior quarter.

Analysis

AbbVie (ABBV) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, AbbVie's Depreciation & Amortization (CF) was $777 million through Jun 30, 2026, up 1.7% year-over-year; for FY2025, it came in at $762 million, down 0.3% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 2.7% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $764 million in FY2024 (+1.6%), $752 million in FY2023 (-3.3%), $778 million in FY2022 (-3.1%) and $803 million in FY2021 (+20.6%).
  • Quarterly Depreciation & Amortization (CF) has moved between $173 million (Q4 2021) and $223 million (Q3 2021) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in five of the last eight quarters, with growth averaging 1.9%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2021 (growth of 27.4%); the worst was Q4 2021 (a decline of 23.8%).
  • Per Business Quant data, ABBV's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $188 million (Q1 2026), $203 million (Q4 2025) and $192 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 1.96 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 194.00 Mn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn -
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 1.93 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 98.00 Mn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 1.62 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 56.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 194.00 Mn
Mar 31, 2026 188.00 Mn
Dec 31, 2025 203.00 Mn
Sep 30, 2025 192.00 Mn
Jun 30, 2025 186.00 Mn
Mar 31, 2025 181.00 Mn
Dec 31, 2024 206.00 Mn
Sep 30, 2024 191.00 Mn
Jun 30, 2024 184.00 Mn
Mar 31, 2024 183.00 Mn
Dec 31, 2023 187.00 Mn
Sep 30, 2023 196.00 Mn
Jun 30, 2023 190.00 Mn
Mar 31, 2023 179.00 Mn
Dec 31, 2022 196.00 Mn
Sep 30, 2022 181.00 Mn
Jun 30, 2022 203.00 Mn
Mar 31, 2022 198.00 Mn
Dec 31, 2021 173.00 Mn
Sep 30, 2021 223.00 Mn
API Access

AbbVie Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ABBV&period=max&api_key=YOUR_API_KEY